Statins don’t revoke cancer risk: study

<p>NEW YORK (Reuters Health) – Despite progressing indications that people holding <span>statins</span> competence have a reduced risk of building <span>melanoma</span>, a vast new investigate of women finds a renouned cholesterol-lowering drugs do zero to forestall a fatal <span>skin cancer</span>.</p>
<p> “For primary impediment (of melanoma) we consider we’re putting a spike into a coffin of that theory,” pronounced Dr. <span>Robert Dellavalle</span>, arch of dermatology during a Denver VA Medical Center, who was not concerned in a new research.</p>
<p> Melanoma is a many fatal of a skin cancers, with 70,000 new cases diagnosed in a U.S. any year and tighten to 9,000 Americans a year failing from a disease.</p>
<p> About 45 million Americans take statins, that embody atorvastatin (Lipitor), lovastatin (Mevacor), pravastatin (Pravachol), rosuvastatin (Crest...